PINK Fundamental Analysis - PERIMETER MEDICAL IMAGING AI

Fundamental Rating

Taking everything into account, PINK scores 3 out of 10 in our fundamental rating. PINK was compared to 15 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of PINK have multiple concerns. PINK shows excellent growth, but is valued quite expensive already.

Quickly go to:

1. Profitability

1.1 Basic Checks

PINK had negative earnings in the past year.

In the past year PINK has reported a negative cash flow from operations.

In the past 5 years PINK always reported negative net income.

In the past 5 years PINK always reported negative operating cash flow.

1.2 Ratios

PINK has a Return On Assets of -239.48%. This is comparable to the rest of the industry: PINK outperforms 46.67% of its industry peers.

PINK has a Return On Equity (-412.07%) which is comparable to the rest of the industry.

		Industry Rank	Sector Rank
ROA	-239.48%
ROE	-412.07%
ROIC	N/A

ROA(3y)-63.49%

ROA(5y)-88.85%

ROE(3y)-86.41%

ROE(5y)-118.03%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

PINK has a better Gross Margin (59.01%) than 66.67% of its industry peers.

PINK's Gross Margin has improved in the last couple of years.

The Profit Margin and Operating Margin are not available for PINK so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	59.01%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y12.47%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

PINK does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for PINK has been increased compared to 1 year ago.

PINK has more shares outstanding than it did 5 years ago.

The debt/assets ratio for PINK is higher compared to a year ago.

2.2 Solvency

PINK has an Altman-Z score of -26.13. This is a bad value and indicates that PINK is not financially healthy and even has some risk of bankruptcy.

With a Altman-Z score value of -26.13, PINK perfoms like the industry average, outperforming 46.67% of the companies in the same industry.

PINK has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.

PINK has a Debt to Equity ratio of 0.02. This is amongst the best in the industry. PINK outperforms 93.33% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.02
Debt/FCF	N/A
Altman-Z	-26.13

ROIC/WACCN/A

WACC7.74%

2.3 Liquidity

PINK has a Current Ratio of 1.21. This is a normal value and indicates that PINK is financially healthy and should not expect problems in meeting its short term obligations.

PINK has a Current ratio of 1.21. This is in the better half of the industry: PINK outperforms 80.00% of its industry peers.

PINK has a Quick Ratio of 1.17. This is a normal value and indicates that PINK is financially healthy and should not expect problems in meeting its short term obligations.

The Quick ratio of PINK (1.17) is better than 93.33% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.21
Quick Ratio	1.17

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 36.89% over the past year.

Looking at the last year, PINK shows a very strong growth in Revenue. The Revenue has grown by 201.31%.

The Revenue has been growing by 354.72% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)36.89%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%62.95%

Revenue 1Y (TTM)201.31%

Revenue growth 3Y354.72%

Revenue growth 5YN/A

Sales Q2Q%157.2%

3.2 Future

Based on estimates for the next years, PINK will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.18% on average per year.

PINK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 119.88% yearly.

EPS Next Y21.56%

EPS Next 2Y18.63%

EPS Next 3Y18.41%

EPS Next 5Y19.18%

Revenue Next Year244.83%

Revenue Next 2Y205.13%

Revenue Next 3Y171.19%

Revenue Next 5Y119.88%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PINK. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PINK. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as PINK's earnings are expected to grow with 18.41% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y18.63%

EPS Next 3Y18.41%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

PINK does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

PERIMETER MEDICAL IMAGING AI

TSX-V:PINK (12/15/2025, 7:00:00 PM)

0.26

+0.04 (+15.56%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)11-12 2025-11-12/amc

Earnings (Next)03-24 2026-03-24/amc

Inst Owners24.49%

Inst Owner ChangeN/A

Ins Owners13.68%

Ins Owner ChangeN/A

Market Cap28.95M

Revenue(TTM)1.89M

Net Income(TTM)-14.35M

Analysts80

Price Target1.89 (626.92%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)25.13%

Min EPS beat(2)22.11%

Max EPS beat(2)28.15%

EPS beat(4)2

Avg EPS beat(4)-8.72%

Min EPS beat(4)-66.34%

Max EPS beat(4)28.15%

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-44.66%

Min Revenue beat(2)-57.22%

Max Revenue beat(2)-32.1%

Revenue beat(4)2

Avg Revenue beat(4)18.14%

Min Revenue beat(4)-57.22%

Max Revenue beat(4)160.4%

Revenue beat(8)4

Avg Revenue beat(8)3.99%

Revenue beat(12)5

Avg Revenue beat(12)-7.2%

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)6.73%

PT rev (3m)6.73%

EPS NQ rev (1m)0%

EPS NQ rev (3m)0%

EPS NY rev (1m)0%

EPS NY rev (3m)7.25%

Revenue NQ rev (1m)-4.69%

Revenue NQ rev (3m)-4.69%

Revenue NY rev (1m)-6.78%

Revenue NY rev (3m)-6.78%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	11.16
P/FCF	N/A
P/OCF	N/A
P/B	6.05
P/tB	6.05
EV/EBITDA	N/A

EPS(TTM)-0.33

EYN/A

EPS(NY)-0.2

Fwd EYN/A

FCF(TTM)-0.16

FCFYN/A

OCF(TTM)-0.14

OCFYN/A

SpS0.02

BVpS0.04

TBVpS0.04

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-239.48%
ROE	-412.07%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	59.01%
FCFM	N/A

ROA(3y)-63.49%

ROA(5y)-88.85%

ROE(3y)-86.41%

ROE(5y)-118.03%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y12.47%

GM growth 5YN/A

F-Score2

Asset Turnover0.31

Health

		Industry Rank	Sector Rank
Debt/Equity	0.02
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.21
Quick Ratio	1.17
Altman-Z	-26.13

F-Score2

WACC7.74%

ROIC/WACCN/A

Cap/Depr(3y)208.17%

Cap/Depr(5y)571.74%

Cap/Sales(3y)624.9%

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)36.89%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%62.95%

EPS Next Y21.56%

EPS Next 2Y18.63%

EPS Next 3Y18.41%

EPS Next 5Y19.18%

Revenue 1Y (TTM)201.31%

Revenue growth 3Y354.72%

Revenue growth 5YN/A

Sales Q2Q%157.2%

Revenue Next Year244.83%

Revenue Next 2Y205.13%

Revenue Next 3Y171.19%

Revenue Next 5Y119.88%

EBIT growth 1Y20.31%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year8.31%

EBIT Next 3Y15.32%

EBIT Next 5Y24.33%

FCF growth 1Y-35.44%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-16.75%

OCF growth 3YN/A

OCF growth 5YN/A

PERIMETER MEDICAL IMAGING AI / PINK.CA FAQ

What is the ChartMill fundamental rating of PERIMETER MEDICAL IMAGING AI (PINK.CA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to PINK.CA.

What is the valuation status of PERIMETER MEDICAL IMAGING AI (PINK.CA) stock?

ChartMill assigns a valuation rating of 0 / 10 to PERIMETER MEDICAL IMAGING AI (PINK.CA). This can be considered as Overvalued.

Can you provide the profitability details for PERIMETER MEDICAL IMAGING AI?

PERIMETER MEDICAL IMAGING AI (PINK.CA) has a profitability rating of 2 / 10.

Can you provide the financial health for PINK stock?

The financial health rating of PERIMETER MEDICAL IMAGING AI (PINK.CA) is 3 / 10.

PERIMETER MEDICAL IMAGING AI (PINK.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

PERIMETER MEDICAL IMAGING AI / PINK.CA FAQ

What is the ChartMill fundamental rating of PERIMETER MEDICAL IMAGING AI (PINK.CA) stock?

What is the valuation status of PERIMETER MEDICAL IMAGING AI (PINK.CA) stock?

Can you provide the profitability details for PERIMETER MEDICAL IMAGING AI?

Can you provide the financial health for PINK stock?